Mergers and Acquisitions: Strategic Legal Advisory
We provide end-to-end advisory for high-stakes corporate deals, ensuring regulatory compliance and commercial alignment from term sheet to closing.
We advised Infinx on its strategic acquisition of i3 Verticals' Healthcare Revenue Cycle Management (RCM) business for approximately USD 96 million. This deal expanded our client's footprint in the US healthcare market, particularly with academic medical centers.
Our team advised Infinx on its acquisition of Glidian, Inc. through a reverse triangular merger. This complex, cross-border transaction strengthened our client's patient access solutions and expanded their presence in the laboratory and healthcare technology market.
We advised Walchandnagar Industries Limited (WIL) on its multi-tranche acquisition of a majority stake in Aicitta Intelligent Technology. This strategic investment expands WIL's defense business into the high-growth sector of unmanned systems and proprietary IP development.
We guided Zeno Health, a health-tech pharmacy platform, on its acquisition of Tablt Pharmacy's assets on a slump sale basis. This transaction was structured to expand Zeno Health's last-mile medicine supply services into underserved markets across Eastern India.
We advised Ind-Swift Laboratories and its promoters on the INR 1,650 crore sale of its API and CRAMS businesses to IndiaRF. The complex deal involved advising on the business sale and a subsequent investment by our client into the acquiring entity.
We advised the founders of PeopleStrong, a leading SaaS provider, and its investor HDFC Bank on the stake sale by Multiples P.E. to Goldman Sachs Alternatives. This USD 130 million transaction highlights our expertise in managing complex, multi-party private equity exits.
We advised Syrma SGS Technology on its strategic joint venture with Italian electronics leader Elemaster. This deal establishes a dedicated manufacturing platform in India for the railway, industrial, and medical electronics sectors, showcasing our cross-border transaction capabilities.
We advised Balrampur Chini Mills on executing definitive agreements to establish India’s first industrial bioplastics (PLA) manufacturing plant. This pioneering project, with an estimated capex of Rs. 2,000 crores, aligns with our focus on sustainability and innovative industrial ventures.
We advised Togai Inc., a usage-based billing infrastructure provider, on its acquisition by Zuora Inc. This deal involved navigating the complexities of a cross-border technology acquisition and advising existing investors like Together Fund and BoldCap on their successful exit.
We advised Infinx on the acquisition of the assets and operations of Medreceivables Advisor, LLC (MRA). This deal strengthened our client's capabilities in specialized pathology coding and billing, expanding their service offerings in the US healthcare revenue cycle management space.
About Mergers & Acquisitions (M&A) Showcase
In every M&A transaction we manage, the real work happens long before the final signature. We prioritize rigorous due diligence and detailed Condition Precedent management, ensuring that complex cross-border or domestic deals do not just close on paper, but function seamlessly in practice. Our approach minimizes post-closing friction by proactively addressing potential regulatory hurdles and integration risks during the drafting phase.
Our Approach to M&A Transactions
We approach mergers and acquisitions not just as a legal requirement, but as a critical business inflection point. Whether you are navigating a cross-border acquisition, a slump sale, or a complex joint venture, our strategy remains consistent: practical risk mitigation.
Key Areas of Focus:
- Structuring for Efficiency: From tax-efficient architecture (Asset Slump Sale vs. Share Purchase) to tranches and escrow mechanisms, we design the transaction structure to maximize value.
- Deep-Dive Due Diligence: We look past the obvious, focusing on identifying red flags, title defects, and regulatory non-compliance that could jeopardize the deal post-closing.
- Regulatory & Anti-Trust Advisory: Navigating the Competition Act and other sectoral regulations is often the biggest bottleneck. We manage filings and compliance to keep your deal timeline on track.
- Director & Founder Protection: We implement specific governance frameworks, such as Section 166-aligned clauses, to protect leadership teams from personal liability risks arising from the transaction.
Why Clients Choose Us:
Our team has successfully advised on transformative deals across the healthcare, tech, and manufacturing sectors. We do not believe in boilerplate drafting. Instead, we customize definitive agreements—such as the SHA or BTA—to reflect the unique commercial realities of your business, ensuring you have the flexibility to scale while maintaining strict legal protection.
Krishnava Dutt
We do not believe that complex laws should be barriers to business growth. Our team works directly with boards and leadership to break down intricate legal structures into clear, actionable strategies, ensuring your M&A goals are met with precision.
Explore our legal practice areas
Find expert counsel for your specific business or corporate needs.
More from Corporate, M&A & Private Equity by Krishnava Dutt